Log In
Print
BCIQ
Print
Print this Print this
 

DX-2400, KD014

  Manage Alerts
Collapse Summary General Information
Company Dyax Corp.
DescriptionHuman mAb against matrix metalloproteinase 14 (MMP14)
Molecular Target Matrix metalloproteinase 14 (MMP14)
Mechanism of ActionMatrix metalloproteinase inhibitor (MMPI)
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner

Kadmon Corp. LLC


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today